TY - JOUR
T1 - Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus
AU - Wildasin, Elena M.
AU - Skaar, Debra J.
AU - Kirchain, William R.
AU - Hulse, Michelle
PY - 1997/1
Y1 - 1997/1
N2 - Noninsulin-dependent diabetes mellitus has historically been treated with diet therapy alone or the addition of an oral hypoglycemic agent such as a sulfonylurea, or the two in combination with insulin. Although these medical interventions lower blood glucose concentrations, they may also potentiate hyperinsulinism through increased serum insulin concentrations. Insulin resistance and hyperinsulinism are associated with cardiovascular risk factors such as hypertriglyceridemia, decreased high-density lipoprotein cholesterol levels, hypertension, and hyperglycemia, among others. Therefore, a desirable therapeutic alternative would lower blood glucose, not result in hyperinsulinism, and have beneficial effects on lipid profiles. Metformin is a biguanide antihyperglycemic agent that provides these effects. When administered to carefully selected patients and monitored appropriately, metformin may prove to be valuable in the treatment of diabetes mellitus and in altering its cardiovascular sequelae.
AB - Noninsulin-dependent diabetes mellitus has historically been treated with diet therapy alone or the addition of an oral hypoglycemic agent such as a sulfonylurea, or the two in combination with insulin. Although these medical interventions lower blood glucose concentrations, they may also potentiate hyperinsulinism through increased serum insulin concentrations. Insulin resistance and hyperinsulinism are associated with cardiovascular risk factors such as hypertriglyceridemia, decreased high-density lipoprotein cholesterol levels, hypertension, and hyperglycemia, among others. Therefore, a desirable therapeutic alternative would lower blood glucose, not result in hyperinsulinism, and have beneficial effects on lipid profiles. Metformin is a biguanide antihyperglycemic agent that provides these effects. When administered to carefully selected patients and monitored appropriately, metformin may prove to be valuable in the treatment of diabetes mellitus and in altering its cardiovascular sequelae.
UR - http://www.scopus.com/inward/record.url?scp=0031037037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031037037&partnerID=8YFLogxK
M3 - Review article
C2 - 9017766
AN - SCOPUS:0031037037
SN - 0277-0008
VL - 17
SP - 62
EP - 73
JO - Pharmacotherapy
JF - Pharmacotherapy
IS - 1
ER -